期刊文献+

疫苗新型佐剂的作用机制和研发进展综述 被引量:5

Research and mechanisms of action of novel vaccine adjuvants:a literature review
原文传递
导出
摘要 接种疫苗是预防传染性疾病的有效措施之一。灭活疫苗、亚单位疫苗、基因工程疫苗等大多存在抗原免疫原性弱的问题,需要添加佐剂以改善疫苗的免疫效果,因此,疫苗的佐剂配方是疫苗研发中非常关键的一部分。近年来,除了已在各类疫苗中广泛使用的铝佐剂外,许多新型佐剂被开发和应用。本文对MF59、Toll样受体激动剂、多糖、免疫刺激复合物、纳米生物佐剂、复合佐剂等新型佐剂的作用机制和研发进展进行了文献综述,为中国未来疫苗佐剂的研制和应用提供参考。 Vaccination is one of the most effective measures to prevent infectious diseases.Many inactivated vaccines,subunit vaccines,and genetically engineered vaccines have weak immunogenicity,and adjuvants are needed to improve their immune effects.Therefore,vaccine adjuvants and their formulation are key parts of vaccine research and development.In recent years,in addition to aluminum adjuvants,which are widely used in certain types of vaccines,many new adjuvants have been developed and are being used.In this article,we review the mechanisms of action and progress on research and development of novel adjuvants including MF59,Toll-like receptor agonists,polysaccharides,immunostimulatory complexes,nanobiologic adjuvants,and complex adjuvants to provide reference for future development and use of vaccine adjuvants in China.
作者 夏芯 朱雅文 周利 朱凤才 李靖欣 Xia Xin;Zhu Yawen;Zhou Li;Zhu Fengcai;Li Jingxin(School of Public Health,Nanjing Medical University,Nanjing 211166,Jiangsu,China;NHC Key Laboratory of Enteric Pathogenic Microbiology,Jiangsu Provincial Center for Disease Control and Prevention,Nanjing 210009,Jiangsu,China;Department of Vaccine Clinical Evaluation,Jiangsu Provincial Center for Disease Control and Prevention,Nanjing 210009,Jiangsu,China)
出处 《中国疫苗和免疫》 CSCD 北大核心 2023年第4期474-482,共9页 Chinese Journal of Vaccines and Immunization
基金 江苏省重点研发计划(BE2021738)。
关键词 疫苗 新型佐剂 作用机制 研发 进展 Vaccine Novel adjuvant Mechanism Research and development Progress
  • 相关文献

参考文献1

二级参考文献18

  • 1吴隼,郭立君,金立杰,罗璇,官桂范,邵华,刘大维,苗立红.ISCOMS重组乙型肝炎疫苗的研究[J].中国生物制品学杂志,2004,17(5):303-306. 被引量:6
  • 2吴晓娟,赵大鹏,冷梅,崔颖杰,张岩,汪春义,戚凤春,郭新,陈云波,何伟,徐建国,付学奇.含IL-2基因的乙型肝炎病毒DNA疫苗的构建及其免疫效果[J].中国生物制品学杂志,2006,19(6):599-602. 被引量:2
  • 3丛中一,包木胜,万敏,王莉,李大鹏,王丽颖,于永利.新型CpG ODN增强乙肝疫苗诱导IgG2a类抗体产生的实验研究[J].中国免疫学杂志,2006,22(11):987-990. 被引量:4
  • 4谭昌耀,袁进,金瓯,蒋丽明,胡波.毕赤酵母表达的含前S1、前S2和S表位乙肝表面抗原疫苗的制备和免疫原性研究[J].生物工程学报,2007,23(4):700-703. 被引量:5
  • 5Page M, Jones CD, Bailey C. A novel, recombinant triple antigen hepatitis B vaccine (Hepacare). Intervirelogy, 2001, 44 ( 2-3 ) :88-97.
  • 6Madalifiski K, Sylvan SP, Hellstrom U, et al. Presence of anti- preS1, anti-preS2, and anti-HBs antibodies in newborns immu- nized with Bio-Hep-B vaccine. Med Sci Monit, 2004, 10 ( 1 ) : PI10-PI17.
  • 7Boland G, Beran J, Lievens M, et al. Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04. Vaccine, 2004, 23(3) : 316-320.
  • 8Howard CR, Sundquist B, Allan J, et al. Preparation and proper- ties of immune-stimulating complexes containing hepatitis B virus surface antigen. J Gen Virol, 1987, 68 ( Pt 9) : 2281-2289.
  • 9Morein B, Sundquist B, Hoglund S, et al. Iscom, a novel struc- ture for antigenic presentation of membrane proteins from enveloped viruses. Nature, 1984, 308 (5958) : 457-460.
  • 10Morein F, Bengtsson KL. Functional aspects of iscoms. Immunol Cell Biol, 1998, 76(4) : 295-299.

共引文献1

同被引文献27

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部